Opthalmologist, engineer and scientist Mark Humayun holds joint appointments at Keck School of Medicine and USC Viterbi School of Engineering. | PHOTO BY ZÉ CARLOS BARRETTA

Opthalmologist, engineer and scientist Mark Humayun holds joint appointments at Keck School of Medicine and USC Viterbi School of Engineering. | PHOTO BY ZÉ CARLOS BARRETTA

Mark S. Humayun, MD, PhD, co-director of the USC Gayle and Edward Roski Eye Institute and director of the USC Institute for Biomedical Therapeutics, has been elected to the National Academy of Inventors (NAI) 2016 Fellows Program, the highest professional distinction accorded solely to academic inventors. Humayun will attend the NAI Fellow induction ceremony at the John F. Kennedy Presidential Library and Museum in Boston next April.

Founded in 2010, NAI Fellows are nominated by their peers and chosen based on their prolific contribution in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society.

Humayun merges medicine and engineering to focus on developing treatments for the most debilitating and challenging eye diseases and holds more than 100 issued patents and patent applications, most in the area of bioimplants for ophthalmology. He is a USC professor with joint appointments in ophthalmology, cell and neurobiology at the Keck School of Medicine of USC, and in biomedical engineering at the USC Viterbi School of Engineering and holds the inaugural Cornelius J. Pings Chair in Biomedical Sciences.

Humayun’s most recognized innovation is his co-creation of the Argus II, manufactured by Second Sight Medical Products Inc., the only FDA approved retinal prosthesis system that allows those with certain blinding diseases to regain some useful vision. Earlier this year, Humayun received the prestigious National Medal of Technology and Innovation, the nation’s highest award for technology achievement, from President Barack Obama.

Humayun will be one of 582 NAI Fellows who represent universities, government agencies and nonprofit research institutions. He is among eight NAI Fellows from USC, including 2016 inductee Shri Narayanan, PhD, professor of electrical engineering and computer science in the USC Viterbi School of Engineering’s Ming Hsieh Department of Electrical Engineering. Narayanan also holds secondary appointments as professor of linguistics at the USC Dornsife College of Letters, Arts and Sciences and professor of pediatrics at Keck School. Humayun also joins USC President C. L. Max Nikias, PhD, who became a NAI Fellow in 2012.

“Mark Humayun is such a deserving recipient of this fellowship from the National Academy of Inventors,” Nikias said. “In advancing technology to change medicine, Professor Humayun does not see boundaries, but rather possibilities.  He exemplifies American ingenuity and has dedicated his career to preventing and reversing blindness through technological innovation.”

“I am honored to be selected a Fellow with the National Academy of Inventors,” Humayun said. “My passion has been to merge the power of technology and engineering to create medical breakthroughs. Often these innovations, such as the Argus II which took more than 20 years from concept to FDA approval, come after long periods of research and development and through collaborating with many talented students and colleagues but the results in changing patient lives is worth the wait and hard work. The environment at USC allows me to surround myself with very talented individuals who help make these ideas a reality.”

“Mark embodies the spirit of innovation and dedication at the USC Roski Eye Institute by pushing the envelope to create biomedical solutions that will make a transformative difference in people’s lives and we congratulate him on this latest honor,” said Rohit Varma, MD, MPH, dean of the Keck School and director of the USC Roski Eye Institute. “Restoring vision and preventing blindness is Mark’s personal ‘moonshot’ and a mission all the physicians and scientists at USC Roski Eye Institute share. We’re proud to have him conducting his research, creating his technological breakthroughs and treating patients at USC and also benefiting patients worldwide.”

by Sherri Snelling